Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical
Pharma
Partners Alvotech, Teva eye 2026 Eylea biosimilar launch
The Eylea biosim has been under FDA review for much of this year. Back in February, the companies said they expected a decision by the end of 2025.
Eric Sagonowsky
Dec 19, 2025 10:40am
Antheia links with TAPI to scale biosynthetic drug ingredients
Nov 20, 2025 8:00am
Teva debuts innovation platform to parry key industry challenges
Nov 19, 2025 8:38am
Alvotech plant issues trigger another FDA biosimilar rejection
Nov 4, 2025 7:40am
Teva execs aren't sweating newly unveiled pharmaceutical tariffs
Jul 30, 2025 11:11am
Europe must restore generic manufacturing autonomy: Teva exec
Jul 1, 2025 8:35am
